| Year |
Citation |
Score |
| 2020 |
Ranjan T, Howard CM, Yu A, Xu L, Aziz K, Jho D, Leonardo J, Hameed MA, Karlovits SM, Wegner RE, Fuhrer R, Lirette ST, Denning KL, Valluri J, Claudio PP. Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series. Translational Oncology. 13: 100755. PMID 32197147 DOI: 10.1016/J.Tranon.2020.100755 |
0.365 |
|
| 2019 |
Sakiyama MJ, Espinoza I, Reddy A, de Carlo F, Kumar A, Levenson AS, Bae S, Zhou X, Claudio PP, Lewin J, Manucha V, Pound CR, Vijayakumar S, Gomez CR. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer. Experimental and Molecular Pathology. PMID 31004600 DOI: 10.1016/J.Yexmp.2019.04.010 |
0.4 |
|
| 2019 |
De Carlo F, Thomas L, Brooke B, Varney ET, Nande R, Boskovic O, Marshall GD, Claudio PP, Howard CM. Microbubble-mediated delivery of human adenoviruses does not elicit innate and adaptive immunity response in an immunocompetent mouse model of prostate cancer. Journal of Translational Medicine. 17: 19. PMID 30635014 DOI: 10.1186/S12967-019-1771-0 |
0.33 |
|
| 2019 |
Carlo FD, Varney ET, Claudio PP, Howard CM. Abstract 4772: Evaluation of immune response following ultrasound targeted gene therapy in a murine model of prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4772 |
0.314 |
|
| 2018 |
Eastham LL, Howard CM, Balachandran P, Pasco DS, Claudio PP. Eating Green: Shining Light on the Use of Dietary Phytochemicals as a Modern Approach in the Prevention and Treatment of Head and Neck Cancers. Current Topics in Medicinal Chemistry. PMID 29332583 DOI: 10.2174/1568026618666180112160713 |
0.362 |
|
| 2018 |
De Carlo F, Thomas L, Nande R, Boskovic O, Marshall G, Claudio PP, Howard CM. Ultrasound targeted gene therapy in a mouse model of prostate cancer: Evaluation of immune response. Journal of Clinical Oncology. 36: 120-120. DOI: 10.1200/Jco.2018.36.6_Suppl.120 |
0.357 |
|
| 2018 |
Ranjan T, Howard CM, Valluri J, Yu A, Aziz K, Jho D, Julien TD, Leonardo J, Alberico A, Cortese A, Denning KL, Claudio PP. Prospective analysis of cancer stem cell drug response assay for glioblastoma patients. Journal of Clinical Oncology. 36: 2057-2057. DOI: 10.1200/Jco.2018.36.15_Suppl.2057 |
0.368 |
|
| 2017 |
Howard CM, Valluri J, Alberico A, Julien T, Mazagri R, Marsh R, Alastair H, Cortese A, Griswold M, Wang W, Denning K, Brown L, Claudio PP. Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients. Translational Oncology. 10: 241-254. PMID 28199863 DOI: 10.1200/Jco.2017.35.15_Suppl.E13544 |
0.385 |
|
| 2016 |
Greco A, Albanese S, Auletta L, De Carlo F, Salvatore M, Howard CM, Claudio PP. Advances in molecular preclinical therapy mediated by imaging. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 27858405 DOI: 10.23736/S1824-4785.16.02944-7 |
0.337 |
|
| 2016 |
Cortese A, Pantaleo G, Amato M, Lawrence L, Mayes V, Brown L, Sarno MR, Valluri J, Claudio PP. A new complementary procedure for patients affected by head and neck cancer: Chemo-predictive assay. International Journal of Surgery Case Reports. 26: 42-46. PMID 27449762 DOI: 10.1016/J.Ijscr.2016.07.013 |
0.374 |
|
| 2015 |
Carper MB, Claudio PP. Clinical potential of gene mutations in lung cancer. Clinical and Translational Medicine. 4: 33. PMID 26603430 DOI: 10.1186/S40169-015-0074-1 |
0.724 |
|
| 2015 |
Koc EC, Haciosmanoglu E, Claudio PP, Wolf A, Califano L, Friscia M, Cortese A, Koc H. Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma. Mitochondrion. 24: 113-21. PMID 26238294 DOI: 10.1016/J.Mito.2015.07.123 |
0.31 |
|
| 2015 |
Morra F, Luise C, Merolla F, Poser I, Visconti R, Ilardi G, Paladino S, Inuzuka H, Guggino G, Monaco R, Colecchia D, Monaco G, Cerrato A, Chiariello M, Denning K, ... Claudio PP, et al. FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. Oncotarget. 6: 12697-709. PMID 25885523 DOI: 10.18632/Oncotarget.3708 |
0.375 |
|
| 2015 |
Claudio PP, Mathis SE, Nande R, Lawrence L, Alberico A, Julien TD, Mazagri RS, Marsh R, Muizelaar P, Denning KL, Valluri J. ChemoID assay for glioblastoma. Journal of Clinical Oncology. 33: e13028-e13028. DOI: 10.1200/Jco.2015.33.15_Suppl.E13028 |
0.372 |
|
| 2014 |
Carper MB, Denvir J, Boskovic G, Primerano DA, Claudio PP. RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells. Genes & Cancer. 5: 420-35. PMID 25568667 DOI: 10.18632/Genesandcancer.43 |
0.749 |
|
| 2014 |
Mathis SE, Alberico A, Nande R, Neto W, Lawrence L, McCallister DR, Denvir J, Kimmey GA, Mogul M, Oakley G, Denning KL, Dougherty T, Valluri JV, Claudio PP. Chemo-predictive assay for targeting cancer stem-like cells in patients affected by brain tumors. Plos One. 9: e105710. PMID 25144312 DOI: 10.1371/Journal.Pone.0105710 |
0.384 |
|
| 2014 |
Wolf MA, Claudio PP. Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin. Nutrition and Cancer. 66: 285-94. PMID 24447182 DOI: 10.1080/01635581.2014.868912 |
0.337 |
|
| 2014 |
Claudio PP, Mathis SE, Nande R, Alberico A, Neto W, Lawrence L, Denvir J, Kimmey GA, Chowdhary AA, Tirona MRBT, Mogul MJ, Julien TD, Mazagri RS, Oakley G, Denning KL, et al. Novel chemosensitivity assay for targeting cancer stem-like cells in brain tumors. Journal of Clinical Oncology. 32: e13012-e13012. DOI: 10.1200/Jco.2014.32.15_Suppl.E13012 |
0.393 |
|
| 2013 |
De Carlo F, Witte TR, Hardman WE, Claudio PP. Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. Plos One. 8: e69760. PMID 23874993 DOI: 10.1371/Journal.Pone.0069760 |
0.371 |
|
| 2013 |
Bagashev A, Fan S, Mukerjee R, Claudio PP, Chabrashvili T, Leng RP, Benchimol S, Sawaya BE. Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein. Cell Cycle (Georgetown, Tex.). 12: 1569-77. PMID 23603988 DOI: 10.4161/Cc.24733 |
0.318 |
|
| 2013 |
Nande R, Greco A, Gossman MS, Lopez JP, Claudio L, Salvatore M, Brunetti A, Denvir J, Howard CM, Claudio PP. Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer. Current Gene Therapy. 13: 163-74. PMID 23531191 DOI: 10.2174/1566523211313030001 |
0.41 |
|
| 2013 |
Valluri J, Claudio PP, Mathis SE, Alberico A, Kimmey GA, Mogul MJ, Sehgal R, Chowdhary AA, Tirona MRBT, Dougherty T. ChemoID assay for anaplastic spinal ependymoma. Journal of Clinical Oncology. 31: e13040-e13040. DOI: 10.1200/Jco.2013.31.15_Suppl.E13040 |
0.378 |
|
| 2013 |
Claudio PP, Valluri J, Mathis SE, Alberico A, Alberico T, Denvir J, Kimmey GA, Mogul MJ, Sehgal R, Chowdhary AA, Mozayen M, Tirona MRBT, Matt LB, Oakley G, Denning KL, et al. Chemopredictive assay for patients with primary brain tumors. Journal of Clinical Oncology. 31: 2089-2089. DOI: 10.1200/Jco.2013.31.15_Suppl.2089 |
0.393 |
|
| 2013 |
Wolf MA, Claudio PP. PP141 Oral Oncology. 49: S142. DOI: 10.1016/J.Oraloncology.2013.03.385 |
0.395 |
|
| 2012 |
Nande R, Di Benedetto A, Aimola P, De Carlo F, Carper M, Claudio CD, Denvir J, Valluri J, Duncan GC, Claudio PP. Targeting a newly established spontaneous feline fibrosarcoma cell line by gene transfer. Plos One. 7: e37743. PMID 22666387 DOI: 10.1371/Journal.Pone.0037743 |
0.726 |
|
| 2012 |
Aimola P, Carmignani M, Volpe AR, Di Benedetto A, Claudio L, Waalkes MP, van Bokhoven A, Tokar EJ, Claudio PP. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. Plos One. 7: e33647. PMID 22448262 DOI: 10.1371/Journal.Pone.0033647 |
0.406 |
|
| 2012 |
Greco A, Mancini M, Gargiulo S, Gramanzini M, Claudio PP, Brunetti A, Salvatore M. Ultrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging. Journal of Biomedicine & Biotechnology. 2012: 519238. PMID 22163379 DOI: 10.1155/2012/519238 |
0.311 |
|
| 2010 |
Mukerjee R, Claudio PP, Chang JR, Del Valle L, Sawaya BE. Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle (Georgetown, Tex.). 9: 4569-78. PMID 21088492 DOI: 10.4161/Cc.9.22.13836 |
0.322 |
|
| 2010 |
Pedersini R, Vattemi E, Claudio PP. Adenoviral gene therapy in high-grade malignant glioma. Drug News & Perspectives. 23: 368-79. PMID 20697604 DOI: 10.1358/Dnp.2010.23.6.1524009 |
0.35 |
|
| 2010 |
Vogiatzi P, Claudio PP. Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer. Expert Review of Anticancer Therapy. 10: 1027-30. PMID 20645691 DOI: 10.1586/Era.10.84 |
0.317 |
|
| 2010 |
Aimola P, Desiderio V, Graziano A, Claudio PP. Stem cells in cancer therapy: From their role in pathogenesis to their use as therapeutic agents. Drug News & Perspectives. 23: 175-83. PMID 20440419 DOI: 10.1358/Dnp.2010.23.3.1489979 |
0.412 |
|
| 2010 |
Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP. Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. Plos One. 5: e10035. PMID 20386701 DOI: 10.1371/Journal.Pone.0010035 |
0.372 |
|
| 2010 |
Greco A, Di Benedetto A, Howard CM, Kelly S, Nande R, Dementieva Y, Miranda M, Brunetti A, Salvatore M, Claudio L, Sarkar D, Dent P, Curiel DT, Fisher PB, Claudio PP. Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 295-306. PMID 19888195 DOI: 10.1038/Mt.2009.252 |
0.398 |
|
| 2009 |
Vogiatzi P, Cassone M, Claudio L, Claudio PP. Targeted therapy for advanced prostate cancer: Looking through new lenses. Drug News & Perspectives. 22: 593-601. PMID 20140279 DOI: 10.1358/Dnp.2009.22.10.1443392 |
0.328 |
|
| 2009 |
Vattemi E, Claudio PP. The feasibility of gene therapy in the treatment of head and neck cancer. Head & Neck Oncology. 1: 3. PMID 19284676 DOI: 10.1186/1758-3284-1-3 |
0.365 |
|
| 2007 |
Vattemi E, Claudio PP. Tumor suppressor genes as cancer therapeutics. Drug News & Perspectives. 20: 511-20. PMID 18080038 DOI: 10.1358/Dnp.2007.20.8.1157613 |
0.414 |
|
| 2007 |
Abbadessa G, Vogiatzi P, Rimassa L, Claudio PP. Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses? Drug News & Perspectives. 20: 307-13. PMID 17878958 DOI: 10.1358/Dnp.2007.20.5.1120218 |
0.361 |
|
| 2007 |
De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H, Giordano A, et al. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. Blood. 110: 1301-7. PMID 17485552 DOI: 10.1182/Blood-2006-12-064865 |
0.439 |
|
| 2007 |
Bagella L, Sun A, Tonini T, Abbadessa G, Cottone G, Paggi MG, De Luca A, Claudio PP, Giordano A. A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo. Oncogene. 26: 1829-39. PMID 17043661 DOI: 10.1038/Sj.Onc.1209987 |
0.391 |
|
| 2007 |
Mattioli E, Vogiatzi P, Sun A, Abbadessa G, Angeloni G, D'Ugo D, Trani D, Gaughan JP, Vecchio FM, Cevenini G, Persiani R, Giordano A, Claudio PP. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. Journal of Cellular Physiology. 210: 183-91. PMID 16998811 DOI: 10.1002/Jcp.20833 |
0.382 |
|
| 2007 |
Vattemi E, Claudio P. Advances and perspectives in gene-based therapy for breast cancer Drugs of the Future. 32: 507. DOI: 10.1358/Dof.2007.032.06.1096368 |
0.382 |
|
| 2006 |
Vattemi E, Claudio PP. Adenoviral gene therapy in head and neck cancer. Drug News & Perspectives. 19: 329-37. PMID 16971969 DOI: 10.1358/Dnp.2006.19.6.1015352 |
0.374 |
|
| 2006 |
Vogiatzi P, Cassone M, Abbadessa G, Claudio PP. The limitless role of p53 in cell cycle machinery: good news or bad news? Cancer Biology & Therapy. 5: 1090-3. PMID 16969127 DOI: 10.4161/Cbt.5.9.3231 |
0.428 |
|
| 2006 |
Genovese C, Trani D, Caputi M, Claudio PP. Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene. 25: 5201-9. PMID 16936738 DOI: 10.1038/Sj.Onc.1209652 |
0.364 |
|
| 2006 |
Howard CM, Forsberg F, Minimo C, Liu JB, Merton DA, Claudio PP. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. Journal of Cellular Physiology. 209: 413-21. PMID 16883597 DOI: 10.1002/Jcp.20736 |
0.302 |
|
| 2006 |
Claudio PP, Cui J, Ghafouri M, Mariano C, White MK, Safak M, Sheffield JB, Giordano A, Khalili K, Amini S, Sawaya BE. Cdk9 phosphorylates p53 on serine 392 independently of CKII. Journal of Cellular Physiology. 208: 602-12. PMID 16741955 DOI: 10.1002/Jcp.20698 |
0.331 |
|
| 2006 |
Vogiatzi P, De Falco G, Claudio PP, Giordano A. How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions. Cancer Biology & Therapy. 5: 371-4. PMID 16627973 DOI: 10.4161/Cbt.5.4.2748 |
0.334 |
|
| 2006 |
Merola E, Mattioli E, Minimo C, Zuo W, Rabitti C, Cicala M, Caviglia R, Pollice L, Gabbrielli A, Giordano A, Claudio PP. Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus. Journal of Cellular Physiology. 207: 512-9. PMID 16447267 DOI: 10.1002/Jcp.20590 |
0.362 |
|
| 2006 |
Giacinti L, Claudio PP, Lopez M, Giordano A. Epigenetic information and estrogen receptor alpha expression in breast cancer. The Oncologist. 11: 1-8. PMID 16401708 DOI: 10.1634/Theoncologist.11-1-1 |
0.302 |
|
| 2006 |
Sanseverino F, Santopietro R, Torricelli M, D'Andrilli G, Russo G, Cevenini G, Bovicelli A, Leoncini L, Scambia G, Petraglia F, Claudio PP, Giordano A. pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade. Cancer Biology & Therapy. 5: 84-8. PMID 16357517 DOI: 10.4161/Cbt.5.1.2345 |
0.396 |
|
| 2005 |
Russo G, Zamparelli A, Howard CM, Minimo C, Bellan C, Carillo G, Califano L, Leoncini L, Giordano A, Claudio PP. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3265-73. PMID 15867222 DOI: 10.1158/1078-0432.Ccr-04-2508 |
0.387 |
|
| 2004 |
Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3509-17. PMID 15161709 DOI: 10.1158/1078-0432.Ccr-03-0662 |
0.37 |
|
| 2004 |
Tonini T, Bagella L, D'Andrilli G, Claudio PP, Giordano A. Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A. Oncogene. 23: 4930-7. PMID 15077161 DOI: 10.1038/Sj.Onc.1207608 |
0.394 |
|
| 2003 |
Russo G, Claudio PP, Fu Y, Stiegler P, Yu Z, Macaluso M, Giordano A. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis. Oncogene. 22: 6959-69. PMID 14534545 DOI: 10.1038/Sj.Onc.1206866 |
0.445 |
|
| 2003 |
Claudio PP, Giordano A. Preparation of retroviral vectors for cell-cycle-targeted gene therapy of lung cancer. Methods in Molecular Medicine. 75: 591-605. PMID 12407766 DOI: 10.1385/1-59259-324-0:591 |
0.393 |
|
| 2002 |
Claudio PP, Tonini T, Giordano A. The retinoblastoma family: twins or distant cousins? Genome Biology. 3: reviews3012. PMID 12225593 DOI: 10.1186/Gb-2002-3-9-Reviews3012 |
0.341 |
|
| 2002 |
Lazzi S, Bellan C, De Falco G, Cinti C, Ferrari F, Nyongo A, Claudio PP, Tosi GM, Vatti R, Gloghini A, Carbone A, Giordano A, Leoncini L, Tosi P. Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. Human Pathology. 33: 723-31. PMID 12196924 DOI: 10.1053/Hupa.2002.125372 |
0.387 |
|
| 2002 |
Pucci B, Claudio PP, Masciullo V, Bellincampi L, Terrinoni A, Khalili K, Melino G, Giordano A. pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation. Oncogene. 21: 5897-905. PMID 12185589 DOI: 10.1038/Sj.Onc.1205750 |
0.393 |
|
| 2002 |
Tonini T, Hillson C, Claudio PP. Interview with the retinoblastoma family members: do they help each other? Journal of Cellular Physiology. 192: 138-50. PMID 12115720 DOI: 10.1002/Jcp.10117 |
0.424 |
|
| 2001 |
Zini N, Trimarchi C, Claudio PP, Stiegler P, Marinelli F, Maltarello MC, La Sala D, De Falco G, Russo G, Ammirati G, Maraldi NM, Giordano A, Cinti C. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. Journal of Cellular Physiology. 189: 34-44. PMID 11573202 DOI: 10.1002/Jcp.1135 |
0.368 |
|
| 2001 |
Galderisi U, Melone MA, Jori FP, Piegari E, Di Bernardo G, Cipollaro M, Cascino A, Peluso G, Claudio PP, Giordano A. pRb2/p130 gene overexpression induces astrocyte differentiation. Molecular and Cellular Neurosciences. 17: 415-25. PMID 11273639 DOI: 10.1006/Mcne.2000.0949 |
0.391 |
|
| 2000 |
Cinti C, Claudio PP, Luca AD, Cuccurese M, Howard CM, D'Esposito M, Paggi MG, Sala DL, Azzoni L, Halazonetis TD, Giordano A, Maraldi NM. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line. Oncogene. 19: 5098-105. PMID 11042698 DOI: 10.1038/Sj.Onc.1203848 |
0.356 |
|
| 2000 |
Perrotti D, Iervolino A, Cesi V, Cirinná M, Lombardini S, Grassilli E, Bonatti S, Claudio PP, Calabretta B. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway. Molecular and Cellular Biology. 20: 6159-69. PMID 10913197 DOI: 10.1128/Mcb.20.16.6159-6169.2000 |
0.339 |
|
| 2000 |
Cinti C, Leoncini L, Nyongo A, Ferrari F, Lazzi S, Bellan C, Vatti R, Zamparelli A, Cevenini G, Tosi GM, Claudio PP, Maraldi NM, Tosi P, Giordano A. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes. The American Journal of Pathology. 156: 751-60. PMID 10702389 DOI: 10.1016/S0002-9440(10)64941-3 |
0.42 |
|
| 2000 |
Claudio PP, Fratta L, Farina F, Howard CM, Stassi G, Numata S, Pacilio C, Davis A, Lavitrano M, Volpe M, Wilson JM, Trimarco B, Giordano A, Condorelli G. Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty. Circulation Research. 85: 1032-9. PMID 10571534 DOI: 10.1161/01.Res.85.11.1032 |
0.386 |
|
| 1999 |
Minimo C, Bibbo M, Claudio PP, De Luca A, Giordano A. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies. Pathology, Research and Practice. 195: 67-70. PMID 10093823 DOI: 10.1016/S0344-0338(99)80072-7 |
0.423 |
|
| 1999 |
Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S, Kang P, Malhotra A, Anversa P. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. The American Journal of Pathology. 154: 567-80. PMID 10027414 DOI: 10.1016/S0002-9440(10)65302-3 |
0.316 |
|
| 1999 |
Pupa SM, Howard CM, Invernizzi AM, De Vecchi R, Giani C, Claudio PP, Colnaghi MI, Giordano A, Ménard S. Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line. Oncogene. 18: 651-6. PMID 9989815 DOI: 10.1038/Sj.Onc.1202363 |
0.445 |
|
| 1998 |
Raschellà G, Tanno B, Bonetto F, Negroni A, Claudio PP, Baldi A, Amendola R, Calabretta B, Giordano A, Paggi MG. The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation. Cell Death and Differentiation. 5: 401-7. PMID 10200489 DOI: 10.1038/Sj.Cdd.4400359 |
0.392 |
|
| 1998 |
Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. Journal of the National Cancer Institute. 90: 1451-60. PMID 9776410 DOI: 10.1093/Jnci/90.19.1451 |
0.395 |
|
| 1998 |
Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. The Journal of Clinical Investigation. 101: 1326-42. PMID 9525975 DOI: 10.1172/Jci316 |
0.32 |
|
| 1998 |
Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP, Giordano A, Kajstura J, Hintze TH, Anversa P. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation. 97: 194-203. PMID 9445173 DOI: 10.1161/01.Cir.97.2.194 |
0.323 |
|
| 1998 |
Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, Nelkin BD, Mabry M. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. The Journal of Clinical Investigation. 101: 153-9. PMID 9421477 DOI: 10.1172/Jci831 |
0.398 |
|
| 1997 |
De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. The Journal of Biological Chemistry. 272: 20971-4. PMID 9261093 DOI: 10.1074/Jbc.272.34.20971 |
0.346 |
|
| 1997 |
De Luca A, Esposito V, Baldi A, Claudio PP, Fu Y, Caputi M, Pisano MM, Baldi F, Giordano A. CDC2-related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues. Journal of Cellular Physiology. 172: 265-73. PMID 9258347 DOI: 10.1002/(Sici)1097-4652(199708)172:2<265::Aid-Jcp13>3.0.Co;2-8 |
0.302 |
|
| 1996 |
Baldi A, Boccia V, Claudio PP, De Luca A, Giordano A. Genomic structure of the human retinoblastoma-related Rb2/p130 gene. Proceedings of the National Academy of Sciences of the United States of America. 93: 4629-32. PMID 8643454 DOI: 10.1073/Pnas.93.10.4629 |
0.338 |
|
| 1995 |
Baldi A, De Luca A, Claudio PP, Baldi F, Giordano GG, Tommasino M, Paggi MG, Giordano A. The RB2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. Journal of Cellular Biochemistry. 59: 402-8. PMID 8567757 DOI: 10.1002/Jcb.240590311 |
0.386 |
|
| 1995 |
Wen SC, Ku DH, De Luca A, Claudio PP, Giordano A, Calabretta B. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A. Experimental Cell Research. 217: 8-14. PMID 7867724 DOI: 10.1006/Excr.1995.1057 |
0.322 |
|
| Show low-probability matches. |